Keratosis

Keratosis is a growth of keratin on the skin. More specifically, it can refer to: * actinic keratosis * seborrheic keratosis* keratosis pilaris (From the Wikpedia article Keratosis.)

Download PDF

Recent Publications on Keratosis:
Clinicopathological study of 21 cases of eyelid actinic keratosis. Background Actinic keratosis (AK) is an intraepidermal malignancy...	18th July, 2008	Department of Ophthalmology, Madrid, Spain.	Int Ophthalmol. 2008 Jul 17;. DOI Direct Link
Collagen XVII/BP180 Protein Expression in Squamous Cell Carcinoma of the Skin Detected With Novel Monoclonal Antibodies in Archived Tissues Using Tissue Microarrays and Digital Microscopy. Collagen XVII/BP180, a hemidesmosomal adhesion protein, is lost during...	18th July, 2008	*Laboratory of Tumor Pathology and Molecular Diagnostics, Bay Zoltan	Appl Immunohistochem Mol Morphol. 2008 Jul 15;. DOI Direct Link
Epidermodysplasia verruciformis. A 29-year-old woman presented for evaluation of an ulcerated nodule on her...	17th July, 2008	Department of Dermatology, New York University, USA.	Dermatol Online J. 2008 May 15;14(5):2.
A novel ATP2A2 missense mutation p.Asp254Gly in Darier disease restricted to the extremities. BACKGROUND: Toll-like receptors (TLR) represent a family of surface...	17th July, 2008		J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S116-8. DOI Direct Link
Dermoscopy: basic concepts. Dermoscopy is a very useful technique for the analysis of pigmented skin...	11th July, 2008	Sector of Dermatology and Post-Graduation Course in Dermatology,	Int J Dermatol. 2008 Jul;47(7):712-9. DOI Direct Link
→View more research publications.

BioNews Results for Keratosis:
Keratosis Pilaris	U.S.Pharmacist:  Jun 14 2008 5:38AM Matching: keratosis

Keratosis Clinical Trials:
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis	Keratosis Intervention: Drug: imiquimod cream

Keratosis Patents:
US Patent No.	Title
7312225	Macrocyclic pyrimidines, their production and use as pharmaceutical agents
7335654	Phosphodiesterase 4 inhibitors
7335671	Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
7335756	Retinoic acid metabolizing cytochrome P450
7338958	Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
→View more patents.

Companies working in the area of Keratosis from Bioportfolio's Biocorporate database :
Company Name
Biofrontera AG Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in... www.biofrontera.com/        View full profile
Biofrontera AG Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in... www.biofrontera.de/        View full profile
Peplin Limited Peplin Limited (Peplin) is a public company focused on the development and commercialisation of prescription human therapeutic products for the treatment of cancer. Peplin is listed on the Australian... www.peplin.com/        View full profile
→View more Keratosis related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Keratosis scientists - we have details of around 845 individuals working on Keratosis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.